Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DU SAUT LE CERF : revenue, balance sheet and financial ratios

SELARL PHARMACIE DU SAUT LE CERF is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in EPINAL (88000), this company of category PME shows in 2025 a net income positive of 185 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DU SAUT LE CERF (SIREN 753028778)
Indicator 2025 2024 2023 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 185 027 € 120 103 € 97 720 € 285 634 € 270 835 € 283 367 € 117 688 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE DU SAUT LE CERF generates positive net income of 185 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 118 k€ -> 185 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

185 027 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 93%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

92.944%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

40.354%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

80.6%

Solvency indicators evolution
SELARL PHARMACIE DU SAUT LE CERF

Sector positioning

Debt ratio
92.94 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of SELARL PHARMACIE DU SAUT ... (92.94) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
40.35% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average

In 2025, the financial autonomy of SELARL PHARMACIE DU SAUT ... (40.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 132.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

132.956

Liquidity indicators evolution
SELARL PHARMACIE DU SAUT LE CERF

Sector positioning

Liquidity ratio
132.96 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average

In 2025, the liquidity ratio of SELARL PHARMACIE DU SAUT ... (132.96) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELARL PHARMACIE DU SAUT LE CERF in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE DU SAUT LE CERF is estimated at 2 939 175 € (range 1 994 538€ - 4 611 971€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1994k€ 2939k€ 4611k€
2 939 175 € Range: 1 994 538€ - 4 611 971€
NAF 5 année 2025

Valuation method used

Net Income Multiple
185 027 € × 15.9x = 2 939 176 €
Range: 1 994 539€ - 4 611 972€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DU SAUT LE CERF with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DU SAUT LE CERF

What is the revenue of SELARL PHARMACIE DU SAUT LE CERF ?

The revenue of SELARL PHARMACIE DU SAUT LE CERF is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DU SAUT LE CERF profitable?

Yes, SELARL PHARMACIE DU SAUT LE CERF generated a net profit of 185 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE DU SAUT LE CERF ?

The headquarters of SELARL PHARMACIE DU SAUT LE CERF is located in EPINAL (88000), in the department Vosges.

Where to find the tax return of SELARL PHARMACIE DU SAUT LE CERF ?

The tax return of SELARL PHARMACIE DU SAUT LE CERF is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DU SAUT LE CERF operate?

SELARL PHARMACIE DU SAUT LE CERF operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.